Top

Journal of Neurology

Published in:

Open Access 01-03-2012 | Letter to the Editors

Acute painful lumbosacral paresthesia after intrathecal rituximab

Authors: J. E. C. Bromberg, J. K. Doorduijn, J. W. Baars, G. W. van Imhoff, R. Enting, M. J. van den Bent

Published in: Journal of Neurology | Issue 3/2012

Excerpt

Dear Sirs, …

Bollen EL, Brouwer RE, Hamers S, Hermans J, Kluin M, Sankatsing SU, Tjak RV, Charvat MV, Kluin-Nelemans JC (1997) Central nervous system relapse in non-Hodgkin lymphoma. A single-center study of 532 patients. Arch Neurol 54:854–859PubMedCrossRef

Recht L, Straus DJ, Cirrincione C, Thaler HT, Posner JB (1988) Central nervous system metastases from non-Hodgkin’s lymphoma: treatment and prophylaxis. Am J Med 84:425–435PubMedCrossRef

Pfreundschuh M, Schubert J, Ziepert M, Schmits R, Mohren M, Lengfelder E, Reiser M, Nickenig C, Clemens M, Peter N, Bokemeyer C, Eimermacher H, Ho A, Hoffmann M, Mertelsmann R, Trumper L, Balleisen L, Liersch R, Metzner B, Hartmann F, Glass B, Poeschel V, Schmitz N, Ruebe C, Feller AC, Loeffler M (2008) Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20 + B-cell lymphomas: a randomised controlled trial (RICOVER-60). Lancet Oncol 9:105–116PubMedCrossRef

Pfreundschuh M, Trumper L, Osterborg A, Pettengell R, Trneny M, Imrie K, Ma D, Gill D, Walewski J, Zinzani PL, Stahel R, Kvaloy S, Shpilberg O, Jaeger U, Hansen M, Lehtinen T, Lopez-Guillermo A, Corrado C, Scheliga A, Milpied N, Mendila M, Rashford M, Kuhnt E, Loeffler M (2006) CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group. Lancet Oncol 7:379–391PubMedCrossRef

Rubenstein JL, Combs D, Rosenberg J, Levy A, McDermott M, Damon L, Ignoffo R, Aldape K, Shen A, Lee D, Grillo-Lopez A, Shuman MA (2003) Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment. Blood 101:466–468PubMedCrossRef

Shah GD, Yahalom J, Correa DD, Lai RK, Raizer JJ, Schiff D, LaRocca R, Grant B, Deangelis LM, Abrey LE (2007) Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma. J Clin Oncol 25:4730–4735PubMedCrossRef

Rubenstein JL, Fridlyand J, Abrey L, Shen A, Karch J, Wang E, Issa S, Damon L, Prados M, McDermott M, O’Brien J, Haqq C, Shuman M (2007) Phase I study of intraventricular administration of rituximab in patients with recurrent CNS and intraocular lymphoma. J Clin Oncol 25:1350–1356PubMedCrossRef

Schulz H, Pels H, Schmidt-Wolf I, Zeelen U, Germing U, Engert A (2004) Intraventricular treatment of relapsed central nervous system lymphoma with the anti-CD20 antibody rituximab. Haematologica 89:753–754PubMed

Antonini G, Cox MC, Montefusco E, Ferrari A, Conte E, Morino S, Latino P, Trasimeni G, Monarca B (2007) Intrathecal anti-CD20 antibody: an effective and safe treatment for leptomeningeal lymphoma. J Neurooncol 81:197–199PubMedCrossRef

10.

Nelson RW, Frank JT (1981) Intrathecal methotrexate-induced neurotoxicities. Am J Hosp Pharm 38:65–68PubMed

11.

Kim S, Chatelut E, Kim JC, Howell SB, Cates C, Kormanik PA, Chamberlain MC (1993) Extended CSF cytarabine exposure following intrathecal administration of DTC 101. J Clin Oncol 11:2186–2193PubMed

12.

Jabbour E, O’Brien S, Kantarjian H, Garcia-Manero G, Ferrajoli A, Ravandi F, Cabanillas M, Thomas DA (2007) Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphocytic leukemia. Blood 109:3214–3218PubMedCrossRef

13.

Ostermann K, Pels H, Kowoll A, Kuhnhenn J, Schlegel U (2011) Neurologic complications after intrathecal liposomal cytarabine in combination with systemic polychemotherapy in primary CNS lymphoma. J Neurooncol 103:635–640PubMedCrossRef

Title: Acute painful lumbosacral paresthesia after intrathecal rituximab
Authors: J. E. C. Bromberg
J. K. Doorduijn
J. W. Baars
G. W. van Imhoff
R. Enting
M. J. van den Bent
Publication date: 01-03-2012
Publisher: Springer-Verlag
Published in: Journal of Neurology / Issue 3/2012
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-011-6190-y

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Acute painful lumbosacral paresthesia after intrathecal rituximab

Excerpt

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2012

Rituximab responsive multiple radiculopathies and cranial nerve palsies in association with chronic lymphocytic leukaemia

The effect of thrombolysis on short-term improvement depends on initial stroke severity

Increased expression of endothelial lipase in symptomatic and unstable carotid plaques

The relationship between clinical and pathological variables in Richardson’s syndrome

Decompressive hemicraniectomy followed by endovascular thrombosuction in a patient with cerebral venous thrombosis

Leonid Ivanovich Omorokov (1881–1971)